Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

IsoPlexis introduces Duomic platform

IsoPlexis recently presented proof-of-concept data from Duomic, its novel functional proteomic + transcriptomic platform. IsoPlexis has demonstrated the ability to simultaneously measure functional protein and gene...

| By Kelley Gipson

Moderna teams up with Stamford nonprofit

Coronavirus vaccine maker Moderna is giving away one of its mRNA-based treatments to a newly launched Stamford nonprofit — with the goal of developing a...

| By Kelley Gipson

Butterfly ultrasound device to be used in space

A pocket-sized ultrasound device invented in Guilford will once again be hitching a ride into space. Researchers for NASA want to see if the average...

| By Kelley Gipson

CoRISMA announces funding for heart device

Yale spinout CoRISMA MCS Systems has announced the closing of a Series A funding round. The company’s lead product is an implanted transcatheter that features wirelessly powered...

| By Kelley Gipson

Cancer research award to UConn resident

Dr. Joshua A. Fein, a third-year resident in the UConn internal medicine residency program and current applicant for hematology/oncology fellowship programs, has been selected by...

| By Kelley Gipson

Undergrads at UConn get research experience

The Undergraduate Research Program at UConn offers students interested in health and biomedical sciences a unique first-hand experience to work at UConn Health. In a...

| By Kelley Gipson

FDA approves Cara’s KORSUVA™ for dialysis patients

Cara Therapeutics and Vifor Pharma report that the FDA has approved KORSUVA™ (difelikefalin) for injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease...